Genelabs Technologies
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids (NCT00082511) | Genelabs Technologies | 2003-07-01 |
| To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids (NCT00053560) | Genelabs Technologies | 2002-12-01 |
| Study of GL701 in Men With Systemic Lupus Erythematosus (NCT00037128) | Genelabs Technologies | 1998-03-01 |
| A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin (NCT00001989) | Genelabs Technologies |
Track Genelabs Technologies automatically
Every clearance here is in the API, with alerts when new ones post.